Nasacort eent

Administration

Intranasal Administration

Administer by nasal inhalation using a metered-dose nasal spray pump.2 3 4 5 8 22

Prime metered-dose spray pump prior to first use and after a period of nonuse (i.e., ≥ 2 weeks).2 22

Gently blow the nose to clear nasal passages.2 Shake inhaler well prior to administration.2 22

Tilt head slightly backward, insert spray tip into one nostril, and point tip toward back of the nose.2 22 Pump the drug into one nostril while holding the other nostril closed and concurrently inspire through the nose.2 22 Repeat this procedure for the other nostril.2 22 Avoid blowing nose for 15 minutes after inhalation.2 22

Dosage

Nasal spray pump delivers about 55 mcg of triamcinolone acetonide per metered spray.2 22

Do not continue intranasal triamcinolone acetonide for >3 weeks in the absence of adequate symptomatic improvement.1 2 16

For self-medication, discontinue therapy and contact a clinician if no improvement after 1 week.22

Pediatric Patients

Seasonal or Perennial Allergic Rhinitis Intranasal Inhalation

Children 2–5 years of age: 55 mcg (1 spray) in each nostril once daily (110 mcg total).2

Children 6–11 years of age: Initially 55 mcg (1 spray) in each nostril once daily (110 mcg total).2 If response inadequate, may increase dosage to 110 mcg (2 sprays) in each nostril once daily (220 mcg total); once symptomatic relief achieved, may reduce dosage to 55 mcg (1 spray) in each nostril once daily (110 mcg total).2

Children ≥12 years of age: 110 mcg (2 sprays) in each nostril once daily (220 mcg total); once symptomatic relief achieved, may reduce dosage to 55 mcg (1 spray) in each nostril once daily (110 mcg total) to maintain symptomatic control.2

Self-medication for Hay Fever or Other Upper Respiratory Allergies Intranasal Inhalation

Children 2–5 years of age: 55 mcg (1 spray) in each nostril once daily (110 mcg total).22

Children 6–11 years of age: 55 mcg (1 spray) in each nostril once daily (110 mcg total).22 If response inadequate, may increase dosage to 110 mcg (2 sprays) in each nostril once daily (220 mcg total); once symptomatic relief achieved, reduce dosage to 55 mcg (1 spray) in each nostril once daily (110 mcg total).22

Children ≥12 years of age: Initially 110 mcg (2 sprays) in each nostril once daily (220 mcg total); once symptomatic relief achieved, reduce dosage to 55 mcg (1 spray) in each nostril once daily (110 mcg total).22

Adults

Seasonal or Perennial Allergic Rhinitis Intranasal Inhalation

110 mcg (2 sprays) in each nostril once daily (220 mcg total); once symptomatic relief achieved, may reduce dosage to 55 mcg (1 spray) in each nostril once daily (110 mcg total) to maintain symptomatic control.2

Self-medication for Hay Fever or Other Upper Respiratory Allergies Intranasal Inhalation

110 mcg (2 sprays) in each nostril once daily (220 mcg total); once symptomatic relief achieved, reduce dosage to 55 mcg (1 spray) in each nostril once daily (110 mcg total).22

Prescribing Limits

Pediatric Patients

Seasonal or Perennial Allergic Rhinitis Intranasal Inhalation

Children 2–5 years of age: Maximum 110 mcg (1 spray in each nostril) daily.2

Children 6–11 years of age: Maximum 220 mcg (2 sprays in each nostril) daily.2

Children ≥12 years of age: Maximum 220 mcg (2 sprays in each nostril) daily.2

Self-medication for Hay Fever or Other Upper Respiratory Allergies Intranasal Inhalation

Children 2–5 years of age: Maximum 110 mcg (1 spray in each nostril) daily.22

Children 6–11 years of age: Maximum 220 mcg (2 sprays in each nostril) daily.22

Children ≥12 years of age: Maximum 220 mcg (2 sprays in each nostril) daily.22

Adults

Seasonal or Perennial Allergic Rhinitis Intranasal Inhalation

Maximum 220 mcg (2 sprays in each nostril) daily.2

Self-medication for Hay Fever or Other Upper Respiratory Allergies Intranasal Inhalation

Maximum 220 mcg (2 sprays in each nostril) daily.22

Special Populations

Hepatic Impairment

No specific dosage recommendations at this time.2 22

Renal Impairment

No specific dosage recommendations at this time.2 22

Geriatric Patients

Select dosage with caution, usually starting at low end of the dosage range, because of age-related decreases in hepatic, renal, and/or cardiac function and potential for concomitant disease and drug therapy.2 (See Geriatric Use under Cautions.)

Do not use Nasacort AQ in a child under 2 years old without the advice of a doctor. Some brands of triamcinolone nasal are not made for use in children. Do not use Nasacort AQ if you are allergic to triamcinolone.

Before using Nasacort AQ, tell your doctor if you are allergic to any drugs, or if you have tuberculosis, asthma, a history of glaucoma or cataracts, any type of infection, or if you have had recent surgery or injury to your nose.

It may take up to a week before your symptoms improve. Keep using the medication as directed and tell your doctor if your symptoms do not improve after 1 week of treatment, or if they get worse any time during treatment.

Nasacort AQ can lower the blood cells that help your body fight infections. This can make it easier for you to bleed from an injury or get sick from being around others who are ill.

Avoid being near people who are sick or have infections. Call your doctor for preventive treatment if you are exposed to chicken pox or measles. These conditions can be serious or even fatal in people who are using steroid medicine.

Do not stop using Nasacort AQ suddenly or you may have unpleasant withdrawal symptoms. Talk with your doctor about using less and less of the medication before stopping completely.